Phthalic Acid

Phthalic Acid

SCHEMBL532853

O=C(O)c1ccccc1C(=O)O.[KH].[KH]

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.93
ALOX15 P16050 1/20 0.93
AKR1C3 P42330 3/20 0.67
NAPRT Q6XQN6 2/20 0.65
KDM4E B2RXH2 1/20 0.65
CA12 O43570 1/20 0.65
CA1 P00915 1/20 0.65
CA2 P00918 1/20 0.65
HMGB1 P09429 1/20 0.65
HPGD P15428 1/20 0.65
CA4 P22748 1/20 0.65
CA6 P23280 1/20 0.65
CA7 P43166 1/20 0.65
SMN1; SMN2 Q16637 1/20 0.65
CA9 Q16790 1/20 0.65
CA14 Q9ULX7 1/20 0.65
MAPT P10636 2/20 0.62
HDAC8 Q9BY41 1/20 0.62
POLB P06746 1/20 0.59
NR4A1 P22736 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phthalic Acid SCHEMBL28122901 1.00 ALDH1A1 (0.93) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL28252361 1.00 ALDH1A1 (0.93) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL109124 1.00 ALDH1A1 (0.93) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL8726392 1.00 ALDH1A1 (0.93) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL8690032 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL195820 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL21494485 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL20503467 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL10891138 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL4286257 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 534 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12529628-B2 Microbeads and preparation method therefor LG CHEM, LTD. (KR) 2026-01-20 US claimed
US-12350534-B2 Extinguishant composition YAMATO PROTEC CORPORATION (JP) 2025-07-08 US claimed
WO-2025000625-A1 CHEMICAL COOLANT AND USE THEREOF IN AEROSOL-BASED FIRE EXTINGUISHING 湖北及安盾消防科技有限公司 2025-01-02 WO claimed
US-20240382793-A1 EXTINGUISHANT COMPOSITION YAMATO PROTEC CORPORATION (JP) 2024-11-21 US claimed
EP-3921075-B1 CLEAVABLE MULTI-ALCOHOL-BASED MICROCAPSULES FIRMENICH & CIE (CH) 2024-06-12 EP claimed
CN-118056892-A Novel lubricant release agent composition 巴拉尔迪有限责任公司 2024-05-21 CN claimed
CN-116516433-B Green rapid preparation method of metal organic framework compound film coating 中国科学院深圳先进技术研究院 2024-04-26 CN claimed
CN-112055580-B Method for preparing microcapsules 弗门尼舍有限公司 2024-01-09 CN claimed
CN-117046026-A Chemical coolant and application thereof in aerosol fire extinguishment 湖北及安盾消防科技有限公司 2023-11-14 CN claimed
US-20230250369-A9 CLEAVEABLE MULTI-ALCOHOL-BASED MICROCAPSULES FIRMENICH SA (CH) 2023-08-10 US claimed
US-20130184499-A1 PREPARATION OF CATALYST FOR SELECTIVE HYDROGENATION OF HYDROGENATABLE PRECURSORS BIOAMBER INTERNATIONAL S.A.R.L. (LU) 2013-07-18 US claimed
WO-2013106519-A1 PREPARATION OF CATALYST FOR SELECTIVE HYDROGENATION OF HYDROGENATABLE PRECURSORS BIOAMBER INTERNATIONAL S.A.R.L. (LU) 2013-07-18 WO claimed
CN-101376659-B Method for purifying camptothecine and derivative thereof SHANGHAI BIOCOMPOUNDS CHEMLAB CO., LTD. (CN) 2011-11-30 CN claimed
CN-101376659-A Method for purifying camptothecine and derivative thereof SHANGHAI NORTHCAROLINA CHEMLAB (CN) 2009-03-04 CN claimed
US-6391262-B1 CONTAINER WITH A TRANSPARENT SIDE WALL, A REMOVEABLE AND SEALABLE COVER AND A SUPPORT TAB HAVING POTASSIUM HYDROGEN PHTHALATE AS A COLOR INDICATOR BRINTON WILLIAM F (US) 2002-05-21 US claimed
US-5643675-A MIXTURES OF THERMOSETTING RESIN, LATENT ACID CATALYST AND ALKALI METAL SALT OF POLYBASIC ACID(AS LIFE EXTENDER), FOR MAKING FOUNDRY CORES OR MOLDS WITH SAND BORDEN, INC. (US) 1997-07-01 US claimed
EP-0653260-A1 Addition for promotion of bench life extension in a hot box binder system BORDEN, INC. (US) 1995-05-17 EP claimed
US-5175354-A Reacting the potassium salt with benzenecarboxylic acid NIPPON STEEL CHEMICAL CO., LTD. (JP) 1992-12-29 US claimed
CN-1062912-A Stable halogen-containing polymer compositions ATOCHEM NORTH AMERICA (US) 1992-07-22 CN claimed
EP-0492803-A1 Stabilized halogen containing polymer compositions ELF ATOCHEM NORTH AMERICA, INC. (US) 1992-07-01 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12529628-B2 Microbeads and preparation method therefor SLC6A11, SLC16A7, SLC5A11 ALDH1A1 1940/4885ALOX15 4334/4885AKR1C3 1478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.